Commitment to Excellence in IVD Diagnostics.


Welcome to Our Rapid Test Centre
Hangzhou Frenovo Biotech aims to be the leader in vitro rapid lateral flow test, dominate the market for disease diagnosis and analyte detection. We dedicated to producing world class high quality test kits.
Covid-19 related tests are launched!
Covid-19 antigen and Flu A+B
We already gained CE certificate for covid-19 antigen and antibody tests and Flu A and B tests.
Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder. The gold standard of laboratory diagnosis is 14-day cell culture with one of a variety of cell lines that can support the growth of influenza virus. Cell culture has limited clinical utility, as results are obtained too late in the clinical course for effective patient intervention. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a newer method that is generally more sensitive than culture with improved detection rates over culture of 2-23%. However, RT-PCR is expensive, complex and must be performed in specialized laboratories. 
The novel corona-viruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel corona- virus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
FRENOVO FLU A+B & COIVD-19 antigen rapid test qualitatively detects the presence of Influenza A and/or Influenza B antigen in nasal swab or throat swab or nasal aspirate specimens, providing results within 15 minutes.
COVID-19 IgG/IgM rapid tests are launched!
The 2019-NCoV is a large family of viruses known to cause colds as well as more serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Novel coronavirus is a novel coronavirus strain that has never been found in humans before.

In more severe cases, infection can lead to pneumonia, severe acute respiratory syndrome, kidney failure and even death.
FRENOVO COVID-19 IgG/IgM rapid test (Whole Blood/ Serum/ Plasma) is a rapid test that utilizes a combination of COVID-19 antigen coated colored particles for the qualitative detection of IgG and IgM antibodies to COVID-19 in human whole blood, serum, or plasma as an aid in the diagnosis of primary and secondary COVID-19 infections.

News and Events

Why us

Hangzhou Frenovo Biotech Co., Ltd. is delicated to R&D and manufacturing of diagnostic test kit with a bunch of exprienced and educated scientists. Located in Zhejiang and founded in 2020, we bear in our mind that high quality and affordable products for clients is essential.

Customized Development

Hangzhou Frenovo Biotech Co., Ltd, also offer customized services. Customized test kits, like sheet's dimension, materials, such as antibodies, antigens, membrance, pads are highly welcomed.


Production Technology

Hangzhou Frenovo Biotech Co., Ltd. have years of efforts on numerous exploratory experiments and mass production practice.
Copyright © 2021, Frenovo Biotech